Arcturus Therapeutics Holdings Inc. Common Stock vs. Johnson & Johnson
ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
$10.87 +13.94%
VS JNJJohnson & Johnson
$276.32 +3.81%
Arcturus Therapeutics Holdings Inc. Common Stock and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ARCT | JNJ | |
|---|---|---|
| Market Cap | $271.16 million | $640.75 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ARCT | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.94% |
ARCT and JNJ split the dividend factors evenly.
Risk & Sentiment
| ARCT | JNJ | |
|---|---|---|
| Short Interest | 0.22% | 0.67% |
ARCT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ARCT overview, ARCT financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.